EDESA BIOTECH, INC. Deferred Tax Liabilities, Property, Plant and Equipment
EDESA BIOTECH, INC. (EDSA) had Deferred Tax Liabilities, Property, Plant and Equipment of $3.00 thousand as of 2025-09-30, per its 10-K filed 2025-12-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2025-12-12
- 2025-09-30: Deferred Tax Liabilities, Property, Plant and Equipment $3.00K.
- 2024-09-30: Deferred Tax Liabilities, Property, Plant and Equipment $2.00K.
- 2023-09-30: Deferred Tax Liabilities, Property, Plant and Equipment $3.00K.
- 2022-09-30: Deferred Tax Liabilities, Property, Plant and Equipment $15.00K.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment |
|---|---|
| 2025-09-30 | $3.00K 10-K · filed 2025-12-12 |
| 2024-09-30 | $2.00K 10-K · filed 2025-12-12 |
| 2023-09-30 | $3.00K 10-K · filed 2024-12-13 |
| 2022-09-30 | $15.00K 10-K · filed 2023-12-15 |
| 2021-09-30 | $18.00K 10-K · filed 2022-12-16 |
| 2020-09-30 | $17.00K 10-K · filed 2021-12-28 |
| 2019-09-30 | $0.00 10-K · filed 2020-12-07 |
| 2018-09-30 | $1.80K 10-K · filed 2018-11-30 |
| 2017-09-30 | $0.00 10-K · filed 2018-11-30 |
| 2016-09-30 | $0.00 10-K · filed 2016-12-14 |
| 2015-09-30 | $0.00 10-K · filed 2016-12-14 |
| 2014-09-30 | $13.60K 10-K · filed 2016-12-14 |
| 2014-08-31 | $14.50K 10-K · filed 2016-12-14 |
| 2013-08-31 | $33.40K 10-K · filed 2015-12-14 |
| 2012-08-31 | $32.70K 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |